Base
Organization2 sanctions listsIran

Tadbir Kish Medical and Pharmaceutical Company

First seen Apr 20, 2023 · Last confirmed Apr 24, 2026 · Last updated Jan 26, 2026

Entity Overview

Full Name
Tadbir Kish Medical and Pharmaceutical Company
Entity Type
Organization (Organization)
Countries
Iran
OpenSanctions ID
NK-3d2JnAy7kn5QoNgJ7pTp5B
First Seen
Apr 20, 2023
Last Confirmed On List
Apr 24, 2026
Last Updated
Jan 26, 2026

Cross-Source Intelligence

Risk Level

Critical

3 lists confirmed

OFAC SDN

Match

Direct SDN search

BIS CSL

Match

Consolidated Screening List

SAM.gov

Clear

No exclusions

Fed Register

2 mentions

Designation notices & actions

Compare All →

Data compiled from OpenSanctions, OFAC SDN, BIS Consolidated Screening List, Federal Register · As of 2026-04-26 · Updates daily

Multi-List Designation

Tadbir Kish Medical and Pharmaceutical Company appears on 3 distinct sanctions and screening lists across multiple jurisdictions, indicating broad international consensus on restriction.

Sanctions Lists (2)

United States1 list
  • us_ofac_sdn
Other Jurisdictions1 list
  • us_trade_csl

Programs & Topics

sanction

Addresses

Kish, Unit 301, 3rd Floor, Sadaf Tower; Kish, Unit A103, 1st Floor, Padena Complex, Iran Blvd; Kish, Unit A301, 1st Floor, Padena Complex, Iran Blvd

Aliases (2)

Also Known As
Tadbir ted va daroye kish
Tadbir Kish Medical and Pharmaceutical Co.

Also Found on Consolidated Screening List (1)

This entity also appears on the BIS Consolidated Screening List (CSL). Cross-screening confirms presence across multiple US government screening databases.

Related Entities (10)

Need automated sanctions monitoring?

Screen entities in bulk, get real-time alerts when sanctions lists update, and integrate compliance checks directly into your trade workflows.

Join the Waitlist

Compliance Disclaimer

This screening data is provided for informational purposes only. Always verify against official government sources — OFAC, EU Official Journal, UN Security Council — before making compliance decisions.